Literature DB >> 7494302

Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.

X Chen1, M C Schmidt, W F Goins, J C Glorioso.   

Abstract

Herpes simplex virus type 1 (HSV-1) establishes latency in human sensory ganglia, during which time the viral genome is transcriptionally silent with the exception of the latency-associated transcripts (LATs). The most abundant LAT is a 2-kb RNA whose biosynthesis is poorly characterized. The 2-kb LAT may be a primary transcript, or its synthesis may involve splicing and/or other forms of processing. Two potential RNA polymerase II promoters (LAP1 and LAP2) upstream of the 2-kb LAT 5' end have been identified. To investigate the role played by LAP1 and LAP2 in the synthesis of the 2-kb LAT under lytic and latent conditions, we analyzed HSV-1 mutants which contain deletions of one or both of these promoters. During lytic infection in cell culture, the cis elements critical for the normal accumulation of the 2-kb LAT were mapped to LAP2, while LAP1 sequences were largely dispensable. The 5' ends of the major 2-kb LATs produced by the wild-type and LAP deletion viruses were examined by primer extension analysis and were all found to be identical (+/- 2 bp). The accumulation of the 2-kb LAT during latent infections of murine trigeminal ganglia was examined by Northern (RNA) blot and by reverse transcription-PCR. In contrast to the results found in lytic infections, the critical cis elements needed for 2-kb LAT accumulation during latency were mapped to LAP1. Deletion of LAP1 resulted in a 500-fold reduction in 2-kb LAT accumulation, whereas deletion of LAP2 resulted in only a 2- to 3-fold reduction. Deletion of both LAP1 and LAP2 resulted in undetectable levels of the 2-kb LAT. Our results indicate that both LAP1 and LAP2 are critical for 2-kb LAT expression but under different conditions. LAP1 is essential for LAT expression during latency, while LAP2 is primarily responsible for LAT expression in lytic infections in cell culture. LAP1 and LAP2 may prove to be functionally independent promoter elements that control 2-kb LAT expression during different stages of HSV-1 infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494302      PMCID: PMC189734     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization.

Authors:  K D Croen; J M Ostrove; L J Dragovic; J E Smialek; S E Straus
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

2.  Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.

Authors:  J P Katz; E T Bodin; D M Coen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons.

Authors:  A T Dobson; T P Margolis; F Sedarati; J G Stevens; L T Feldman
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

4.  In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1.

Authors:  J Zwaagstra; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

Review 5.  HPRT: gene structure, expression, and mutation.

Authors:  J T Stout; C T Caskey
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

6.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.

Authors:  R Ramakrishnan; D J Fink; G Jiang; P Desai; J C Glorioso; M Levine
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

9.  A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.

Authors:  W F Goins; L R Sternberg; K D Croen; P R Krause; R L Hendricks; D J Fink; S E Straus; M Levine; J C Glorioso
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  The promoter of Alzheimer's disease amyloid A4 precursor gene.

Authors:  J M Salbaum; A Weidemann; H G Lemaire; C L Masters; K Beyreuther
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  40 in total

1.  Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.

Authors:  H Berthomme; J Thomas; P Texier; A Epstein; L T Feldman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells.

Authors:  Edward A Burton; Chang-Sook Hong; Joseph C Glorioso
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.

Authors:  K Wang; L Pesnicak; S E Straus
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript.

Authors:  Gail Henderson; Tareq Jaber; Dale Carpenter; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

Review 7.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

8.  A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus.

Authors:  S H Chen; M F Kramer; P A Schaffer; D M Coen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus.

Authors:  Alex Petrucelli; Michael Rak; Lora Grainger; Felicia Goodrum
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2.

Authors:  S W French; M C Schmidt; J C Glorioso
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.